Ampersand Capital Partners Sells MedVenture Technology to Helix Medical

Private equity firm Ampersand Capital Partners has sold MedVenture Technology Corp. to Helix Medical.

The sale price was not disclosed.

Helix Medical, a division of the Freudenberg Group, is a manufacturer for the medical device and healthcare industries with 10 manufacturing operations worldwide. Medical manufacturing capabilities include design and development, silicone and thermoplastic molding and extrusion, complex catheter systems, assembly, packaging and engineering services.

MedVenture develops and manufactures minimally invasive surgical devices and catheter-based devices for medical device companies.

Ampersand Capital Partners, based in Wellesley, Mass., describes itself as a middle market private equity firm with a focus on growth equity investments in the Healthcare sector.

 

Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.thehealthcareinvestor.com/admin/trackback/288227
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.





Blog Authors

Amber McGraw Walsh

Amber McGraw Walsh Amber Walsh is a partner with McGuireWoods LLP focusing on healthcare transactional work and regulatory matters. Her experience includes representationMore...

Geoff Cockrell

Geoff Cockrell As a partner with the firm, Geoff has a wide scope of expertise spanning mergers and acquisitions, senior andMore...

Twitter Feed

@healthcareinvestor McGuireWoods' Most Recent Twitter Posts